相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients
Qiyi Zhao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages
Di Huang et al.
CANCER RESEARCH (2017)
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Shicheng Su et al.
CELL RESEARCH (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Hyperprogressive disease with anti-PD-1 and anti-PD-L1
Vicki Brower
LANCET ONCOLOGY (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma
Qiyi Zhao et al.
ONCOTARGET (2016)
BTLA identifies dysfunctional PD-1-expressing CD4(+) T cells in human hepatocellular carcinoma
Qiyi Zhao et al.
ONCOIMMUNOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Daniel Sanghoon Shin et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Catherine de Martel et al.
HEPATOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
Yago Pico de Coana et al.
TRENDS IN MOLECULAR MEDICINE (2015)
miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program
Shicheng Su et al.
NATURE COMMUNICATIONS (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Shicheng Su et al.
CANCER CELL (2014)
Hepatocellular carcinoma: clinical frontiers and perspectives
Jordi Bruix et al.
GUT (2014)
Immune Checkpoint Blockade in Hepatocellular Carcinoma: Current Progress and Future Directions
Tai Hato et al.
HEPATOLOGY (2014)
Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
Alison Crawford et al.
IMMUNITY (2014)
Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages
Shicheng Su et al.
ONCOIMMUNOLOGY (2014)
Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity
Christine Pasero et al.
IMMUNOLOGY LETTERS (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy
Christine Pasero et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Activated CD69+ T Cells Foster Immune Privilege by Regulating IDO Expression in Tumor-Associated Macrophages
Qiyi Zhao et al.
JOURNAL OF IMMUNOLOGY (2012)
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
Jr-Wen Shui et al.
NATURE (2012)
TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)
Carl F. Ware et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients
Qiyi Zhao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling
Jr-Wen Shui et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
S. J. O'Day et al.
ANNALS OF ONCOLOGY (2010)
Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM
Theresa L. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Joern C. Albring et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
M. L. del Rio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation
Guifang Cai et al.
IMMUNOLOGICAL REVIEWS (2009)
Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction
Xikui Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding Microenvironment
Timothy C. Cheung et al.
JOURNAL OF IMMUNOLOGY (2009)
Unconventional ligand activation of herpesvirus entry mediator signals cell survival
Timothy C. Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cancer immunologists and cancer biologists: Why we didn't talk then but need to now
George C. Prendergast et al.
CANCER RESEARCH (2007)
B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation
Carsten Krieg et al.
NATURE IMMUNOLOGY (2007)
Balancing co-stimulation and inhibition with BTLA and HVEM
Kenneth M. Murphy et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway
TC Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator
LC Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
分享论文
